Keywords: حداکثر سفتی لخته; PSD; potentially survivable death; TIC; trauma-induced coagulopathy; PDHA; platelet-derived hemostatic agent; MCF; maximum clot firmness; CBC; complete blood count; ROTEM; rotational thromboelastometry; SEM; standard error of the mean; Platelet; Thrombocy
مقالات ISI حداکثر سفتی لخته (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: حداکثر سفتی لخته; ACT; activated clotting time; aPTT; activated partial thromboplastin time; CT; clot time; EXTEM; extrinsically activated tests of ROTEM assays activated with tissue factor; FFP; fresh frozen plasma; FIBTEM; extrinsically activated tests of ROTEM assays ac
Keywords: حداکثر سفتی لخته; AUC30; area under the flow pressure curve; CFT; clot formation time; CT; clotting time; CTI; corn trypsin inhibitor; MCF; maximum clot firmness; ML; maximum lysis; OT; occlusion time; PAI-1; plasminogen activator inhibitor type 1; ROTEM; rotational thromb
Keywords: حداکثر سفتی لخته; A488-FDP; AlexaFluor488-containing fibrin degradation products; AUC; area under curve; CCCP; carbonyl cyanide chlorophenylhydrazone; CR; clot retraction; CT; clotting time; DIC; disseminated intravascular coagulation; FITC; fluorescein isothiocyanate; GP;
Keywords: حداکثر سفتی لخته; Hct; haematocrit level; PLT; platelet count; PRP; platelet rich plasma; PPP; platelet poor plasma; CT; clotting time; CFT; clot formation time; MCF; maximum clot firmness; α; alpha angle; Factors of influence; Haematocrit level; Platelet count; In-vitro;
Keywords: حداکثر سفتی لخته; APTT; Activated partial thromboplastin time; ASIS; recombinant active site-inhibited factor VIIa; BD; brain dead; BSA; Bovine serum albumin; CCP; Cerebral perfusion pressure; CT; Clotting time; CTI; Corn trypsin inhibitor; ETP; endogenous thrombin potenti
Keywords: حداکثر سفتی لخته; HCT; Haematocrit; CCHD; Cyanotic congenital heart disease; CT; Clot time; CFT; Clot formation time; MCF; Maximum clot firmness; CF; Clauss fibrinogen concentration; WBFC; Whole blood fibrinogen concentration; PT; Prothrombin time; APTT; Activated partial
Comprehensive characteristics of the anticoagulant activity of dabigatran in relation to its plasma concentration
Keywords: حداکثر سفتی لخته; APTT; activated partial thromboplastin time; APTT-Cepha; APTT using Cephascreen® (Diagnostica Stago) reagent; APTT-PSL; APTT using Pathromtin®SL (Siemens Healthcare) reagent; ANOVA; analysis of variance; CAT; calibrated automated thrombinography; CT; cl
Adding to the complexity of fetal and neonatal alloimmune thrombocytopenia: Reduced fibrinogen binding in the presence of anti-HPA-1a antibody and hypo-responsive neonatal platelets
Keywords: حداکثر سفتی لخته; 26-4; monoclonal anti-HPA-1 antibody 26-4; ADP; adenosine diphosphate; ANOVA; analysis of variance; APC; Allophycocyanin; AUC; area under the curve; BSA; bovine serum albumin; CD; cluster of differentiation; CFT; clot formation time; CPD; citrate phosphat
Improved antithrombotic activity and diminished bleeding side effect of a PEGylated αIIbβ3 antagonist, disintegrin
Keywords: حداکثر سفتی لخته; PEG; polyethylene glycol; Rn; rhodostomin; PRn; PEGylated rhodostomin; SDS-PAGE; sodium dodecyl sulfate polyacrylamide gel electrophoresis; ACD; acid citrate dextrose; PPP; platelet-poor plasma; PRP; platelet-rich plasma; PS; platelet suspension; PGE1; pr
Regular ArticlePlatelet-related fibrinolysis resistance in patients suffering from PV. Impact of clot retraction and isovolemic erythrocytapheresis
Keywords: حداکثر سفتی لخته; ASA; aspirin; CR; clot retraction; CLT; clot lysis time; ECP; erythracytapheresis procedure; MCF; maximum clot firmness; PAI-1; plasminogen activator inhibitor-1; PV; polycythemia vera; PRP; platelet rich plasma; RBC; red blood cells; TF; tissue factor; t
Regular ArticlePeroxynitrite may affect clot retraction in human blood through the inhibition of platelet mitochondrial energy production
Keywords: حداکثر سفتی لخته; CRR; clot retraction rate; ROTEM; rotational thromboelastometry; CT; clotting time; MCF; maximum clot firmness; PRP; platelet-rich plasma; ODQ; H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one; CCCP; Carbonyl cyanide 3-chlorophenylhydrazone; TMRM; tetramethylrh
Whole blood rotation thromboelastometry (ROTEM®) profiles in subjects with non-neoplastic portal vein thrombosis
Keywords: حداکثر سفتی لخته; WB; Whole Blood; PVT; Portal Vein Thrombosis; CT; Clotting Time; CFT; Clot Formation Time; MCF; Maximum Clot Firmness; aPTT; activated Partial Thromboplastin Time; PT; Prothrombin Time; INR; International Normalized Ratio; ROC; Receiver Operating Characte
Regular articleFibrinogen concentrate and cryoprecipitate but not fresh frozen plasma correct low fibrinogen concentrations following in vitro haemodilution
Keywords: حداکثر سفتی لخته; CFT; Clot formation time; FC 2; Clottagen®; CT; Clotting time; CP; Cryoprecipitate; FFP; Fresh frozen plasma; FC 1; Haemocomplettan®; HES; Hydroxyethyl starch; MCF; Maximum clot firmness; Fibrinogen deficiency; Fresh frozen plasma; Cryoprecipitate coagu